Welcome to LookChem.com Sign In|Join Free

CAS

  • or

72457-26-2

Post Buying Request

72457-26-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

72457-26-2 Usage

Description

4-(4-METHOXYPHENYL)BUTAN-1-AMINE is an organic compound with the molecular formula C11H17NO. It is a derivative of butan-1-amine, featuring a 4-methoxyphenyl group attached to the fourth carbon. 4-(4-METHOXYPHENYL)BUTAN-1-AMINE is known for its potential applications in the pharmaceutical industry due to its unique structural properties.

Uses

Used in Pharmaceutical Industry:
4-(4-METHOXYPHENYL)BUTAN-1-AMINE is used as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique structure allows for the development of new drugs with specific therapeutic properties.
Used in Drug Discovery:
4-(4-METHOXYPHENYL)BUTAN-1-AMINE is used as a starting material in the discovery of an orally-active nonsteroidal androgen receptor pure antagonist. 4-(4-METHOXYPHENYL)BUTAN-1-AMINE and its derivatives are being studied to understand the structure-activity relationships, which can lead to the development of more effective drugs for treating various medical conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 72457-26-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,2,4,5 and 7 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 72457-26:
(7*7)+(6*2)+(5*4)+(4*5)+(3*7)+(2*2)+(1*6)=132
132 % 10 = 2
So 72457-26-2 is a valid CAS Registry Number.
InChI:InChI=1/C11H17NO/c1-13-11-7-5-10(6-8-11)4-2-3-9-12/h5-8H,2-4,9,12H2,1H3

72457-26-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(4-METHOXYPHENYL)BUTAN-1-AMINE

1.2 Other means of identification

Product number -
Other names Benzenebutanamine,4-methoxy

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:72457-26-2 SDS

72457-26-2Relevant articles and documents

Sequential hydroaminomethylation/Pd-catalyzed hydrogenolysis as an atom efficient route to valuable primary and secondary amines

October, Jacquin,Mapolie, Selwyn F.

supporting information, (2021/04/12)

The facile synthesis of valuable primary and secondary amines is reported using a sequential procedure of hydroaminomethylation and Pd-catalyzed hydrogenolysis. The hydroaminomethylation reaction was catalyzed by a cationic Rh(I) iminopyridyl complex and the N-alkylated benzylamines were produced with high chemoselectivity, albeit as mixtures of linear and branched products. Performing the hydrogenolysis reaction using 10% Pd/C, provided access to valuable primary and secondary amines which have applications in the surfactant, pharmaceutical and polymer industries.

Heterocyclization involving benzylic C(sp3)-H functionalization enabled by visible light photoredox catalysis

Pandey, Ganesh,Laha, Ramkrishna,Mondal, Pradip Kumar

supporting information, p. 9689 - 9692 (2019/08/15)

A general and efficient method for heterocyclization involving benzylic C(sp3)-H functionalization enabled by visible light photoredox catalysis to access a wide range of structurally diverse oxygen as well as nitrogen heterocycles up to a gram scale is reported. The potential application of this new methodology is demonstrated by the total synthesis of (-)-codonopsinine and (+)-centrolobine. Herein it is proposed that selectfluor, unlike a fluorinating reagent, acts as an oxidative quencher and a hydrogen radical acceptor.

COMPOUNDS FOR TREATMENT OF CYSTIC FIBROSIS

-

Paragraph 00239, (2015/01/16)

Described herein are compounds, compositions, and methods of their use for the treatment of cystic fibrosis.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 72457-26-2